Association for Value-Based Cancer Care, Inc.
For Immediate Release:
May 14, 2014. Over 250 oncology healthcare professionals, practice managers, and managed care executives convened in Los Angeles, California, this past week to network and exchange ideas with colleagues from all over the country. The Association for Value-Based Cancer Care (AVBCC) Fourth Annual Conference took place at Loews Hollywood Hotel, and served as an opportunity for attendees to improve and sustain their companies and institutions, while improving patient access and quality of cancer care.
This year’s conference featured 20 educational sessions and 15 abstracts, 3 poster award presentations, 3 panel discussions, 3 “Meet the Experts” roundtable sessions, a special session highlighting value-based care for multiple myeloma, and an exhibit hall featuring more than 15 sponsor booths. Key presentations focused on some of the hottest topics in cancer care today, including personalized medicine, cancer care risk models, cancer care delivery, and use of big data in oncology care decisions.
Each day of the 2014 AVBCC Conference had a unique theme, giving multidisciplinary stakeholders an opportunity to view key aspects of cancer care from expert providers’ and payers’ perspectives.
On Tuesday, May 6, Grant Lawless, RPh, MD, FACP, and Gary Owens, MD, co-chaired sessions that showcased “Principles in Value and Market Access." Presentations focused on access and reimbursement issues, calculating and communicating oncology product value, new risk models in cancer care, and global trends in cancer management.
Wednesday, May 7 was “Government and Employers Day”. Jayson Slotnik, JD, MPH, and F. Randy Vogenberg, PhD, RPh, presided over educational sessions targeting policymakers and employers. Topics included the future of healthcare reform; debates regarding cancer care delivery; and innovative insurance, benefit design, and coverage trends.
On Thursday, May 8, sessions were related to “Personalized Medicine and Payers.” In presentations led by Grant Lawless, RPh, MD, FACP, and Michael Kolodziej, MD, conference attendees gained insights about the value of personalized therapies and prognostic testing, the role of big data in oncology decision-making, and the impact of personalized medicine on the future of cancer care.
The final conference day, Friday, May 9, was “Oncology Practice Management, Advocacy, and Navigation Day.” Session co-chairs Linda Bosserman, MD, FACP, and Vicki Kennedy, LCSW, moderated presentations regarding innovations in oncology practice management and care delivery, and shared the perspectives of patients, providers, and the healthcare community on value-based cancer care.
Three poster award winners were recognized in 3 different categories. Each of the following individuals were awarded the opportunity to present their data during the meeting in recognition of their outstanding submissions: Jacqueline Hall, Marco daCosta DiBonaventura, Ronda Copher, Claudio Faria, and Rose Lorenzo in the category of Policy, Advocacy, and Economy; Nicolas Lewine, Doria Cole, Brandon Wade, and Gary Gustavsen in the category of Implications of Personalized Medicine on Payers in Realizing Cost Efficiency; and Shaji Kumar, Ann Engebretson, Francis Buadi, Martha Lacy, Angela Dispenzieri, Mei Sheng Duh, Marie-Hélène Lafeuille, Patrick Lefebvre, Wendy Cheng, Katherine Dea, Mark Yap, Shanmugapriya Saravanan, Debra Rembert, Debra Patt, Liviu Niculescu, Esprit Ma, Maureen Quick, and S. Vincent Rajkumar in the category of Patient and Survivor Care.
At the meeting’s end, program chair Craig Deligdish, MD, addressed attendees with heartfelt closing comments. “Thank you to the people who make this meeting possible. Every day of this meeting and all of our speakers were outstanding…This meeting is different from any others that I attend; it brings more to the table because of the diversity of participants. We look forward to seeing you all at next year’s conference in Washington.”
Gary Owens, MD, one of the AVBCC Conference chairs, agreed, “A distinctive feature of the AVBCC Conference is that it brings together multiple oncology stakeholders and allows them to present their unique perspectives. Conference attendees learn challenges faced by other oncology care stakeholders. While we might not always agree with each other, we cannot move the ball forward without a forum for communication and better understanding of the multidimensional issues facing all of us.”
Highlights and interviews from the Fourth Annual AVBCC Conference will be featured in an upcoming issue of Value-Based Cancer Care®, the official publication of AVBCC. This journal provides a forum for payers, providers, and the entire oncology team to consider cost-value issues particular to cancer treatments.
The Fifth Annual AVBCC Conference will be held May 3 to 6, 2015, at the Omni Shoreham Hotel in Washington, DC.
About the Association for Value-Based Cancer Care™ (AVBCC) www.avbcconline.org
The mission of AVBCC is to provide a forum for payers, providers, and the entire oncology team to consider and evaluate the cost-value issues particular to cancer treatments and its impact on patient care and outcomes. This unique focus is achieved through discussions and collaborations with those involved in evaluating therapies, treating patients, and paying for care.
AVBCC is the fastest growing national specialty organization dedicated to improving the care of cancer patients and their quality of life, by discussing, considering, and evaluating the value equation as it relates to new and existing cancer therapies. This organization, which currently consists of more than 500 members, was established to provide a network for payers and oncology healthcare professionals to interact and network in order to promote optimal care for patients and their families.
About Value-Based Cancer Care® (VBCC) www.valuebasedcancer.com
VBCC is the official publication of the Association for Value-Based Cancer Care. The journal provides a forum for payers, providers, and the entire oncology team to consider the cost-value issues particular to cancer treatments. This unique focus is achieved through news coverage from major hematology/oncology meetings and the cancer literature, supplemented with commentaries and perspectives from those involved in evaluating therapies, treating patients, and paying for care.